ATE484748T1 - Testverfahren zur bestimmung von analyten mittels analytanalogen - Google Patents

Testverfahren zur bestimmung von analyten mittels analytanalogen

Info

Publication number
ATE484748T1
ATE484748T1 AT04768267T AT04768267T ATE484748T1 AT E484748 T1 ATE484748 T1 AT E484748T1 AT 04768267 T AT04768267 T AT 04768267T AT 04768267 T AT04768267 T AT 04768267T AT E484748 T1 ATE484748 T1 AT E484748T1
Authority
AT
Austria
Prior art keywords
binding
binding agent
analyte
site
antibodies
Prior art date
Application number
AT04768267T
Other languages
English (en)
Inventor
Colin Henry Self
Original Assignee
Selective Antibodies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selective Antibodies Ltd filed Critical Selective Antibodies Ltd
Application granted granted Critical
Publication of ATE484748T1 publication Critical patent/ATE484748T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT04768267T 2003-09-01 2004-08-31 Testverfahren zur bestimmung von analyten mittels analytanalogen ATE484748T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0320459.1A GB0320459D0 (en) 2003-09-01 2003-09-01 Assay methods and materials
PCT/GB2004/003718 WO2005022150A2 (en) 2003-09-01 2004-08-31 Assay methods and materials for distinguishing analytes and analyte analogues

Publications (1)

Publication Number Publication Date
ATE484748T1 true ATE484748T1 (de) 2010-10-15

Family

ID=28686717

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04768267T ATE484748T1 (de) 2003-09-01 2004-08-31 Testverfahren zur bestimmung von analyten mittels analytanalogen

Country Status (9)

Country Link
US (1) US8062855B2 (de)
EP (1) EP1664773B1 (de)
JP (1) JP4657210B2 (de)
AT (1) ATE484748T1 (de)
AU (1) AU2004268163B2 (de)
CA (1) CA2537494A1 (de)
DE (1) DE602004029589D1 (de)
GB (1) GB0320459D0 (de)
WO (1) WO2005022150A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0707870D0 (en) 2007-04-23 2007-05-30 Selected Antibodies Ltd Assay Devices and Methods and Components for use Therein
EP2277048B1 (de) * 2008-04-02 2013-03-27 Vivacta Limited Verfahren zur wahrnehmung einer chemikalie
CN104040350B (zh) 2011-12-19 2016-05-18 弗·哈夫曼-拉罗切有限公司 用于检测多特异性结合物的游离结合搭档的方法
US10119978B2 (en) 2013-03-15 2018-11-06 Wallac Oy System and method for determining risk of diabetes based on biochemical marker analysis
US9726681B2 (en) 2013-08-07 2017-08-08 Siemens Healthcare Diagnostics Inc. Compositions and methods for detecting cortisol
US20210396762A1 (en) * 2020-06-19 2021-12-23 Encodia, Inc. Methods for peptide analysis employing multi-component detection agent and related kits
CN110231490B (zh) * 2018-08-30 2021-12-28 南方科技大学 一种探针及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434236A (en) * 1982-10-20 1984-02-28 E. I. Du Pont De Nemours & Co. Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
DE3624464A1 (de) * 1986-07-19 1988-01-28 Boehringer Mannheim Gmbh Verfahren zum nachweis eines analyten sowie hierfuer geeignetes mittel
US5468651A (en) * 1987-11-28 1995-11-21 Cambridge Patent Developments Limited Method for determining haptens, use of method and components useful in method
EP0396570B1 (de) * 1987-11-28 1994-07-20 Cambridge Patent Developments Limited Bestimmungsverfahren, seine verwendung und komponenten
US5980895A (en) * 1995-10-13 1999-11-09 The United States Of America As Represented By The Department Of Health And Human Services Immunotoxin containing a disulfide-stabilized antibody fragment joined to a Pseudomonas exotoxin that does not require proteolytic activation
US20010024795A1 (en) * 1997-02-26 2001-09-27 Khaw Ban-An Immunoassay technique using multispecific molecules
US6451980B1 (en) * 1997-02-26 2002-09-17 Ban-An Khaw Signal enhancement of bispecific antibody-polymer probe for immunoassay use
US20020062010A1 (en) * 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US6372712B1 (en) * 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand

Also Published As

Publication number Publication date
JP4657210B2 (ja) 2011-03-23
DE602004029589D1 (de) 2010-11-25
US8062855B2 (en) 2011-11-22
WO2005022150A3 (en) 2005-08-04
WO2005022150A2 (en) 2005-03-10
EP1664773A2 (de) 2006-06-07
CA2537494A1 (en) 2005-03-10
JP2007504439A (ja) 2007-03-01
AU2004268163A1 (en) 2005-03-10
US20070178543A1 (en) 2007-08-02
EP1664773B1 (de) 2010-10-13
AU2004268163B2 (en) 2011-07-14
GB0320459D0 (en) 2003-10-01

Similar Documents

Publication Publication Date Title
ATE449337T1 (de) Assay
ATE309393T1 (de) Verfahren zum qualitativen und/oder quantitativen nachweis von zellen
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE432947T1 (de) Menschliche antikörper als detektionsreagenzien
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
CY1107490T1 (el) Μεθοδος για την ταυτοποιηση δειγματος σε θηλαστικα καθως και κιτ για την εκτελεση αυτης της μεθοδου
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
WO2005036123A3 (en) Methods for substantially simultaneous evaluation of a sample containing a cellular target and a soluble analyte
ATE540979T1 (de) Leptinantagonist und verfahren zur quantitativen messung von leptin
DE60222816D1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
WO2006034278A3 (en) Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
DE60332382D1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
DE602004029589D1 (de) Testverfahren zur bestimmung von analyten mittels analytanalogen
DE50306501D1 (de) Verfahren zur quantitativen bestimmung mehrerer analyten
ATE392621T1 (de) Verfahren zur quantifizierung von glykiertem protein
ATE539350T1 (de) Verfahren zum nachweis oder zum bestimmen von hbv
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
WO2004076684A3 (en) Compositions and methods for the detection of mammalian muscle troponin i
ATE511650T1 (de) Verfahren zum nachweis von antikörpern einer bestimmten klasse über einen immunkomplex spezifischen antikörper
ATE547161T1 (de) Verfahren zur quantitativen bestimmung von poloxameren
ATE437372T1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties